- Service Name
Celsius Therapeutics
- Industry
Pharmaceuticals, biotechnology, precision medicine, drug discovery
- Main Value Proposition
Celsius Therapeutics aims to develop and deliver innovative medicines that significantly impact the lives of patients with immune-mediated diseases.
- Description
Celsius Therapeutics is a biotechnology company focused on developing precision medicines for patients with cancer and autoimmune diseases. The company aims to leverage innovative approaches to transform patient care and outcomes.
- Key Features
Innovative medicines; Focus on immune-mediated diseases; Precision medicine development; Global reach with ~50,000 employees
- Use Cases
The service is most valuable for patients suffering from cancer and autoimmune diseases, healthcare providers seeking advanced treatment options, and researchers in the field of biotechnology.
- Competitive advantages
Strong backing from AbbVie; Expertise in precision medicine; Access to extensive resources and global network
- Strengths
Celsius Therapeutics benefits from its innovative approach to drug development, a strong partnership with AbbVie, and a dedicated focus on addressing complex immune-mediated diseases.
- Positioning
Celsius Therapeutics positions itself as a leader in the biotechnology sector, focusing on innovative solutions for complex health challenges.
- Audience
The target users include patients with cancer and autoimmune diseases, healthcare professionals, and researchers in biotechnology and pharmaceuticals.
- CTA
Explore
- Tags
biotechnology
precision medicine
immune-mediated diseases
cancer treatment
- Tagline
Celsius Therapeutics is now a part of AbbVie
- Tone of Voice
Innovative, compassionate, professional
- Differentiation
Celsius Therapeutics differentiates itself by integrating advanced biotechnology and artificial intelligence in drug discovery, focusing on precision medicine tailored to individual patient needs.
- Brand Positioning
Celsius Therapeutics is positioned as a cutting-edge biotechnology company under the umbrella of AbbVie, emphasizing its commitment to transforming patient lives through advanced therapies.
- Founded
2018-01-01
- Founders
Aviv Regev
Christoph Lengauer
Jeffrey Bluestone
Ramnik Xavier
Vijay Kuchroo